> Contact
> Homepage
> Site map
> Links

About HIFU
About Ablatherm
  Overview
  History
  Treatment Procedure
  Follow-up
Clinical Information
Clinical Results
Clinical Trials


Published Abstracts
& Articles
Video Clips
 You are here : Physicians > HIFU - Ablatherm > About Ablatherm > History
In 1989, INSERM unit U281(National Institute for health and Medical Research), Urology service of the Edouard Herriot Hospital Lyon, France and EDAP Technomed have joined their efforts and initiated a research project in France. This project was to develop an efficient and minimally invasive treatment for localized prostate cancer (stages T1-T2). After ten years for development, the Ablatherm was CE marked (European approval) and the FDA gave approval for the United States to conduct a clinical study.

Today thousands patients have been treated in several European centers.

® Ablatherm is aregistered trademark of EDAP.
© Copyright 2002 EDAP. All rights reserved.